首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1736688

全球植入式醫療設備市場：市場規模（依產品類型、材料類型、最終用戶和地區）、未來預測

Global Implantable Medical Devices Market Size By Product Type (Cardiovascular Implants, Orthopedic Implants, Breast Implants), By Material Type (Metallic, Ceramic), By End- User (Hospitals, Ambulatory Surgical Centers), By Geographic Scope And Forecast

出版日期: 2025年05月06日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

植入式醫療設備市場規模及預測

2024 年植入式醫療設備市場規模為 1,084.4 億美元，預計到 2032 年將達到 1,797.3 億美元，2026 年至 2032 年的複合年成長率為 6.52%。

植入式醫療設備(IMD) 指植入人體用於治療疾病、監測生理參數或輔助治療的專用設備或器材。這些器械通常由生物相容性材料製成，以確保與人體組織和功能相容。例如，心律調節器、人工電子耳、胰島素幫浦和神經刺激設備。

植入式微創醫療器材 (IMD) 透過強化藥物治療和持續監測生命徵象，在心血管疾病、糖尿病和神經病變等慢性疾病的管理中發揮關鍵作用。將 IMD 植入體內，可以在需要時進行直接干預，從而有可能降低治療的侵入性並改善患者的預後。

這些醫療設備正日益廣泛應用於各醫學領域。透過即時監測數據並進行自適應響應，它們能夠提供精準、個人化的醫療干預。 IMD 技術的未來改進旨在提升功能性、耐用性和小型化，從而降低出現問題的風險並提高患者舒適度。生物可吸收植入、用於遠端監控的無線連接以及用於預測性診斷的人工智慧整合都是未來的潛在發展方向。

IMD 在生物電子學和再生醫學等發展中領域也具有廣闊前景，它們可以超越傳統醫療技術，在恢復或改善身體機能方面發揮重要作用。

全球植入式醫療設備市場動態

影響全球植入式醫療設備市場的關鍵市場動態是：

關鍵市場促進因素

人口老化：人口老化推動了對植入式醫療設備的需求。根據世界衛生組織 (WHO) 的數據，預計2015年至2050年間，全球60歲及以上人口的比例將成長近一倍，從12%增至22%。這種人口結構變化導致與老齡化相關的疾病發生率上升，其中許多疾病需要植入式醫療設備。

醫療保健支出不斷成長：全球醫療保健支出不斷成長，導致現代醫療技術的採用率不斷提高。美國醫療保險和醫療補助服務中心預測，從2019年到2028年，美國國家醫療保健支出將以每年平均5.4%的速度成長，到2028年將達到6.2兆美元。

技術進步：植入器械的技術進步正在改善病患的治療效果。 2020年，美國食品藥物管理局(FDA) 批准了59種創新醫療設備，其中許多是植入式器械，這表明該領域正在快速發展。

主要挑戰

生物相容性與材料選擇：植入式醫療設備(IMD) 必須採用與人體相容的材料製成，以避免發炎和排斥等不良反應。生物相容性測試和生物材料科學的進步持續推動安全性和性能的提升。

病患接受度與心理影響：病患對植入式醫療器材 (IMD) 的接受度取決於操作流程、器械可見度和心理影響等因素。向患者和醫護人員普及 IMD 的益處和風險，對於幫助他們做出明智的決定並提高患者接受度至關重要。

手術技術和植入程序：植入IMD需要精準的手術技術和技能，以確保其在體內正確定位，同時降低損傷和感染的風險。微創手術和機器人輔助技術的進步有助於應對這些挑戰。

成本與可負擔性：開發和生產植入式醫療器材 (IMD) 需要大量的研發、製造和監管成本，這可能會影響病患的可負擔性和可近性。平衡創新與成本效益是一項持續的挑戰。

主要趨勢：

無線連接和遠端監控具有無線連接功能的植入式醫療設備(IMD) 可即時向醫療保健提供者傳輸數據，從而提高遠端監控能力。這一趨勢將促進主動醫療管理、早期療育以及根據患者俱體資訊調整個人化治療方案。

智慧植入與人工智慧：人工智慧的進步正在推動能夠定期調整和反應的智慧植入的研發。這些植入可以自動監測生理數據，檢測異常情況並調整治療方案，從而提高治療效果和患者預後。

以患者為中心的設計：如今，植入式醫療器材 (IMD) 的設計趨勢是優先考慮患者的舒適度、美觀度和易用性。使用者友善的介面、符合人體工學的設計以及整合的患者回饋，都有助於提高治療的可接受性和依從性。

全球市場不斷擴張：由於醫療成本上漲、人口老化以及慢性病盛行率上升，IMD市場正在不斷擴張。亞太地區和拉丁美洲的新興經濟體醫療基礎設施不斷改善，患者人數不斷增加，為IMD製造商提供了成長潛力。

Implantable medical devices (IMDs) are specialized equipment or appliances that are implanted into the human body to treat medical problems, monitor physiological parameters, or give therapeutic assistance. These devices are usually composed of biocompatible materials to ensure compatibility with bodily tissues and functions. Pacemakers, cochlear implants, insulin pumps, and neurostimulators are some such examples.

IMDs play an important role in the management of chronic ailments such as cardiovascular disease, diabetes, and neurological disorders by providing focused medications and continuously monitoring vital signs. Their incorporation into the body enables direct intervention at the point of need, reducing the invasiveness of treatments and perhaps enhancing patient outcomes.

These devices are increasingly being used across a wide range of medical fields. They provide accurate and individualized healthcare interventions by monitoring data in real time and responding adaptively. Future improvements in IMD technology aim to improve functionality, durability, and miniaturization, lowering the risk of problems and increasing patient comfort. Bioresorbable implants, wireless connectivity for remote monitoring, and artificial intelligence integration for predictive diagnosis are all potential developments for the future.

IMDs have also shown promise in developing disciplines such as bioelectronics and regenerative medicine, where they potentially play critical roles in restoring and improving bodily functioning beyond traditional medical techniques.

Global Implantable Medical Devices Market Dynamics

The key market dynamics that are shaping the global implantable medical devices market include:

Key Market Drivers:

Aging Population: The aging population drives demand for implantable medical devices. According to the World Health Organization, the proportion of the global population over the age of 60 is anticipated to nearly double between 2015 and 2050, from 12% to 22%. This demographic change is increasing the prevalence of age-related illnesses, many of which require implanted devices.

Increasing Healthcare Expenditure: Global healthcare spending is increasing, leading to higher adoption of modern medical technologies. The Centers for Medicare & Medicaid Services predicted that national health spending in the United States would increase at an average annual rate of 5.4% between 2019 and 2028, reaching $6.2 trillion by 2028.

Technological Advancements: Technological advancements in implanted devices are improving patient outcomes. In 2020, the US Food and Drug Administration (FDA) authorized 59 innovative medical devices, many of which were implantable, demonstrating the field's rapid advancement.

Key Challenges:

Biocompatibility and Material Selection: To avoid unpleasant reactions like inflammation or rejection, implantable medical devices (IMDs) must be made from materials that are compatible with the human body. Biocompatibility testing and improvements in biomaterial science are continuing efforts to enhance safety and performance.

Patient Acceptance and Psychological Impact: Patients' acceptance of IMDs can vary depending on factors such as surgery, device visibility, and psychological effects. Educating patients and healthcare providers on the benefits and risks of IMDs is critical for making educated decisions and increasing patient acceptance rates.

Surgical Techniques and Implantation Procedures: IMD implantation involves precise surgical skills and techniques to reduce damage and infection risks while also ensuring the correct location within the body. Advances in minimally invasive surgery and robotic-assisted techniques are helping to resolve these challenges.

Cost and Affordability: The development and production of IMDs incur significant research, manufacturing, and regulatory expenditures, which might have an impact on patient affordability and accessibility. Balancing innovation with cost-effectiveness is an ongoing challenge.

Key Trends:

Wireless Connectivity and Remote Monitoring: Implantable Medical Devices (IMDs) with wireless connectivity can transmit real-time data to healthcare providers, which improves remote monitoring capabilities. This movement promotes proactive healthcare management, early intervention, and individualized therapy adjustments based on patient-specific information.

Smart Implants and Artificial Intelligence: Advances in AI are encouraging the creation of smart implants that can respond adaptively and regularly. These implants can automatically monitor physiological data, detect anomalies, and alter therapy, thereby enhancing treatment efficacy and patient outcomes.

Patient-Centric Design: There is a trend toward creating IMDs that prioritize patient comfort, aesthetics, and usability. User-friendly interfaces, ergonomic designs, and integrated patient feedback all help to increase therapy acceptance and adherence.

Global Market Expansion: The IMD market is growing due to rising healthcare costs, aging populations, and an increasing prevalence of chronic diseases. Emerging countries in Asia-Pacific and Latin America offer growth possibilities for IMD producers, driven by improved healthcare infrastructure and expanding patient.

Global Implantable Medical Devices Market Regional Analysis

Here is a more detailed regional analysis of the global implantable medical devices market:

North America:

North America currently holds the dominant position in the implantable medical device market. The North American region, particularly the United States and Canada, has a high prevalence of chronic diseases, which drives demand for implantable medical devices (IMDs). According to Centers for Disease Control and Prevention (CDC) data from 2022, 60% of adults in the United States had at least one chronic disease, with 40% having two or more. According to the American Heart Association, cardiovascular disorders impact 48% of US people in 2019 and remain a leading cause of death.

Furthermore, the International Diabetes Federation estimates that diabetes prevalence in North America will reach 49.9 million individuals by 2045, up from 37.7 million in 2021. These worrisome rates highlight the vital need for innovative treatment modalities such as pacemakers, implanted cardioverter-defibrillators, and insulin pumps, resulting in significant growth in the IMD market throughout the region.

North America's robust healthcare system, particularly in the United States and Canada, is a key driver of the implanted medical devices (IMDs) market. According to the American Hospital Association, there will be over 6,000 hospitals in the United States by 2023 that are equipped with cutting-edge equipment capable of performing complicated implant procedures.

North America has a large concentration of competent healthcare professionals, with the United States alone accounting for over 758,500 active physicians and surgeons, according to the Bureau of Labor Statistics. This vast network of qualified specialists skilled in IMD procedures promotes the effective adoption and deployment of breakthrough medical technology, accelerating market progress throughout the region.

Asia Pacific:

The Asia Pacific region is poised for the fastest growth in the implantable medical device market. Government initiatives in the Asia-Pacific region are essential to driving the growth of the implantable medical devices (IMD) market. Healthcare expenditure in Southeast Asia has increased significantly in recent years, growing from 3.5% of GDP in 2000 to 4.4% in 2018, according to the World Health Organization. This growing trend indicates increased investment in healthcare infrastructure and services.

The Asia-Pacific implantable medical devices (IMDs) market is experiencing strong growth, driven by demographic factors such as a growing population and increasingly aging demographics. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the region's population is expected to grow from 4.3 billion in 2020 to 4.7 billion in 2050. The proportion of people over the age of 65 is predicted to double from 13% in 2020 to 26% in 2050 across Asia and the Pacific.

Global Implantable Medical Devices Market: Segmentation Analysis

The Global Implantable Medical Devices Market is Segmented on the basis of Product Type, Material Type, End-User, And Geography.

Implantable Medical Devices Market, By Product Type

Cardiovascular Implants
Orthopedic Implants
Breast Implants
Dental Implants
Ophthalmic Implants
Cochlear Implants

Based on Product Type, the market is bifurcated into Cardiovascular Implants, Orthopedic Implants, Breast Implants, Breast Implants, Dental Implants, Ophthalmic Implants, and Cochlear Implants. Cardiovascular implants dominate the implanted medical device market. This is because cardiovascular disorders are extremely common over the world. However, orthopedic implants are predicted to rise the fastest due to an aging population and increased need for joint replacements and fracture treatment solutions.

Implantable Medical Devices Market, By Material Type

Metallic
Ceramic
Polymer

Based on Material Type, the market is segmented into Metallic, Ceramic, and Polymer. Metals are currently the most common materials utilized in implantable medical devices. This is because they provide higher strength, durability, and biocompatibility in applications such as bone plates, joint replacements, and stents. However, polymers are projected to be the fastest-expanding category. Their advantages, such as flexibility, cheaper cost, and suitability for drug delivery, are driving their widespread use in catheters, heart valves, and wound dressings.

Implantable Medical Devices Market, By End-User

Hospitals
Ambulatory Surgical Centers
Multi-Specialty Clinics

Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Multi-Specialty Clinics. Hospitals dominate the implantable medical device market. This is owing to their ability to perform sophisticated procedures, house advanced technology, and provide specialized treatment for chronic disorders that frequently necessitate implantable devices. However, ambulatory surgical facilities (ASCs) experience the most rapid expansion. This trend is being driven by the rising acceptance of minimally invasive procedures, lower costs when compared to hospitals, and a growing patient preference for convenient outpatient settings.

Key Players

The "Global Implantable Medical Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson, Smith & Nephew Plc, BIOTRONIK SE & Co. KG, LivaNova Plc, Cochlear Limited. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Implantable Medical Devices Market Recent Developments
In October 2019, Medtronic got FDA breakthrough device designation for their fully implantable left ventricular assist device (LVAD) for patients with advanced heart failure. This accreditation will allow the company to deliver more effective therapy or diagnostics for life-threatening diseases, increasing its business size.

1 INTRODUCTION OF GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model

5 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT TYPE

5.1 Overview
5.2 Cardiovascular Implants
5.3 Orthopedic Implants
5.4 Breast Implants
5.5 Dental Implants
5.6 Ophthalmic Implants
5.7 Cochlear Implants

6 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET, BY MATERIAL TYPE

6.1 Overview
6.2 Metallic
6.3 Ceramic
6.4 Polymer

7 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET, BY END- USER

7.1 Overview
7.2 Hospitals
7.3 Ambulatory Surgical Centers
7.4 Multi-Specialty Clinics

8 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Medtronic Plc
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Abbott Laboratories
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Boston Scientific Corporation
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Stryker Corporation
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Johnson & Johnson
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Zimmer Biomet Holdings, Inc.
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Smith & Nephew Plc
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 BIOTRONIK SE & Co
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 LivaNova Plc
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Cochlear Limited
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments